This week Dr Giulia Orlando, a postdoctoral researcher in the Haematopoietic Stem Cell Biology Group has been announced as one of five new Leukaemia UK John Goldman Fellows for 2021.
The Fellowships, created in honour of Professor John Goldman, aim to support early career researchers to pursue novel research to treat blood cancer. To be successful applicants must demonstrate their potential as leaders of the future, pursuing research with the potential to impact the understanding and treatment of blood cancer.
Dr Orlando said: “During my John Goldman Fellowship I will study a rare form of childhood cancer, juvenile myelomonocytic leukaemia (JMML), characterised by alterations in RAS genes within cells. No target treatment is currently available for this type of leukaemia, and the only curative option is bone marrow transplant. Even after transplant, 35% of patients relapse. By studying the molecular mechanisms behind RAS driven gene regulation, I hope that this research might lead to new targeted treatments being employed to improve patient outcome.”
For a full list of awardees, please visit the Leukaemia UK website